UnknownNot Applicable

Pelvic Embolisation to Reduce Recurrent Varicose Veins - Primary

United Kingdom270 participantsStarted 2014-03

Plain-language summary

The aim of this study is to identify whether the treatment of pelvic venous reflux (pelvic coil embolisaton) in females with leg varicose veins, who have a proven contribution to their leg varicose veins from pelvic reflux, have a reduction in recurrence after varicose vein surgery.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female gender * Presenting with primary varicose veins in one or both legs with ultrasound --pelvic venous reflux in at least one trunk communicating with the leg varicose veins * Over 18 years old * Able to understand and give consent * Willing to attend for follow ups over five year period Exclusion Criteria: * Pelvic reflux does not communicate with the varicose veins to be treated in the legs * If pelvic venous reflux communicates and contributes to varicose veins in one leg, but not the other, only the leg with a pelvic venous contribution will be entered into the study. * Currently pregnant or plans for pregnancy in the next five years * Under 18 years of age. * Unable to understand or give consent. * Any vascular malformation of the pelvis or legs, apart from that diagnosed as venous reflux disease. * Any medical condition likely to cause death or serious ill health within the next five years. * Any deep venous obstruction or reflux.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in recurrent varicose veins or venous reflux

Timeframe: 6 weeks post surgery, 6 months post surgery, 1 year post surgery, 2 years post surgery, 3 years post surgery, 4 years post surgery, 5 years post surgery

Trial details

NCT IDNCT01901731

SponsorThe Whiteley Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-09

Contact for this trial

Briony Hudson

01483 477180 bh00047@surrey.ac.uk

View on ClinicalTrials.gov More Varicose Veins trials